Influence on [(18)F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumor

BACKGROUND: Anti-programmed cell death 1 (PD-1) antibody is an immune checkpoint inhibitor, and anti-PD-1 therapy improves the anti-tumor functions of T cells and affects tumor microenvironment. We previously reported that anti-PD-1 treatment affected tumor glycolysis by using 2-deoxy-2-[(18)F]fluor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Mayu, Suzuki, Motofumi, Kono, Yusuke, Nakajima, Kohei, Matsuda, Takuma, Kuge, Yuji, Ogawa, Mikako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080890/
https://www.ncbi.nlm.nih.gov/pubmed/32189078
http://dx.doi.org/10.1186/s13550-020-0608-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080890/
https://www.ncbi.nlm.nih.gov/pubmed/32189078
http://dx.doi.org/10.1186/s13550-020-0608-4

Ejemplares similares